Morten S. Busk-Mortensen

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

In Vitro Characterization of the Bacteria-derived Hypoxia-selective Cytotoxin BE-43547.

In Vitro Characterization of the Bacteria-derived Hypoxia-selective Cytotoxin BE-43547.

Journal: Anticancer research

Published: October 04, 2023

In vitro hypoxia responsiveness of [18F] FDG and [18F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scaling.

In vitro hypoxia responsiveness of [18F] FDG and [18F] FAZA retention: influence of shaking versus stagnant conditions, glass versus polystyrene substrata and cell number down-scaling.

Journal: EJNMMI radiopharmacy and chemistry

Published: March 10, 2020

PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 18, 2012

Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.

Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 16, 2011

In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.

In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.

Journal: BMC cancer

Published: September 17, 2010

Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.

Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 14, 2010

Combretastatin-induced hypertension and the consequences for its combination with other therapies.

Combretastatin-induced hypertension and the consequences for its combination with other therapies.

Journal: Vascular pharmacology

Published: September 03, 2010

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 30, 2009

Resolution in PET hypoxia imaging: voxel size matters.

Resolution in PET hypoxia imaging: voxel size matters.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 29, 2008

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.

Journal: International journal of cancer

Published: March 21, 2008

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 25, 2008

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.

Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.

Journal: International journal of radiation oncology, biology, physics

Published: June 10, 2007

Showing 1-12 of 12

Last Updated: 09/26/2026